in Psychology from the University of Vermont, received an M.D. Dr. Countouriotis also serves on the Board of Directors at Passage Bio and as Chairperson of the Board of Directors at Recludix Pharma. This unicorn startup is a payment processor that serves the needs of over 110k European merchant customers of all sizes. Acalabrutinib is also currently being tested in multiple Phase I/II studies in solid tumours, as monotherapy or in combination with immune checkpoint inhibitors or other standard of care regimens. At the time, automation was already in place, which allowed the company to keep costs low. From 2007 to 2010, Dr. Dukes was the President and Chief Executive Officer, and a member of the board of directors, of Essentialis Therapeutics, a clinical stage biotechnology company focused on the development of breakthrough medicines for the treatment of rare metabolic diseases. Its BTK inhibitor, ACP-196, also known as acalabrutinib, is currently in clinical development. Copyright 2023 CB Information Services, Inc. All rights reserved. Dr. Dukes previously served as Senior Vice-President and Head of Business Development and Licensing for Merck Research Laboratories through May 2016. While the Netherlands is a flat country, its startup ecosystem has seen plenty of peaks, and 2022 promises to be another year full of opportunities for Dutch businesses to raise their success. Microsoft, Netflix, Uber, and Slack are among its clients. Earlier in her career, Dr. Countouriotis led development of products for Pfizer and Bristol-Myers Squibb, including Sutent, Mylotarg, Bosulif and Sprycel. Its products, tools and omnichannel solutions are building blocks that help organisations to streamline discussions using their consumers chosen channels, like SMS, Voice, WhatsApp, WeChat, Messenger, and Email. Acerta Pharma is a leader in the field of covalent binding technology and is applying this technology to create novel, highly selective therapies for cancer. You can read more about your. Small molecule cancer therapies are developed by Acerta Pharma. The company wants to invest in its dedicated employees since they are the foundation of its success. Funding Rounds- 7 CBI websites generally use certain cookies to enable better interactions with our sites and services. Learn more. Elasticsearch, Kibana, Beats, and Logstash (formerly known as the ELK Stack), free and paid proprietary features (formerly known as X-Pack), Elastic Cloud (a family of SaaS solutions that includes the Elasticsearch Service), and Elastic Cloud Enterprise are all developed by this unicorn. He holds a B.S. The startup offers features like product and content management, email marketing, affiliate marketing, payment via Hotpay, PCI Compliance and CSE Security, analytics reports, and more. More than 500 people work at its Amsterdam headquarters and offices in New York, Singapore, Hong Kong, Milan, and Cluj-Napoca. Flow Traders has started trading in cryptocurrency and blockchain as well since 2019. Anyone can manage online launches, develop landing sites, and construct email marketing campaigns with Klickpages features. Study of Acalabrutinib (ACP-196) Versus Ibrutinib in Previously Treated AstraZeneca purchased a 55 per cent stake in the company in December 2015. More than 100,000 people have joined the Elasticsearch meetup community. In 2019, it established an AI section to support its hardware and software innovations. Its non-hierarchical approach encourages development and creativity. Micropayments, which were extensively utilised for online games and ringtones, were also made possible. Mollies value increased to 5.4 billion euros as a result. From 2013 to 2016, Mr. Johnson rose to Chief Executive Officer of Acerta Pharma, an oncology-focused pharmaceutical company, where he spearheaded acalabrutinib from early to late-stage global clinical development. At our recently expanded site at Oss in the Netherlands, we have core capabilities in target identification, target validation, lead generation and compound optimization. Flow Traders has been a primary trading firm and one of the largest liquidity providers in the world since 2004, specialising in Exchange Traded Products (ETPs). The Dutch AMBER Alert system was one of the first big customers of the startup. Promote your product offering to tech buyers. [7] Acerta's lead drug, Calquence (acalabrutinib) was approved by the FDA for mantle cell lymphoma in 2017 and CLL in 2020. It added iDEAL functionality to its offering in 2006. This round boosted the total amount raised to $104 million. Vincerx Pharma's executive team, experts in innovative medicines Dr. Countouriotis received training at the University of California, Los Angeles and at the Fred Hutchinson Cancer Research Center in the Pediatric Hematology-Oncology Program. Acerta Pharma B.v. (a Member Of The Astrazeneca Group) specialises in pharmaceuticals. Dr. Krejsa has led early- and late-phase nonclinical and clinical translation programs for diverse small molecule and protein therapeutics in oncology, autoimmune and allergy indications. Mr. Mei holds a BS in Biochemistry and Molecular Biology from The University of California, Santa Cruz. Acerta Pharma, a member of the AstraZeneca Group, is creating novel therapies intended for the treatment of cancer and autoimmune diseases. Prior to this, he was an Equity Research Analyst covering Global Pharma and Biotech companies at various financial institutions. It also has a public API, which is considered a move ahead of the European PSD2 directive. Adyen began growing globally in 2012, with operations in San Francisco, Paris, and London. 1 email found . The Life Sciences & Health Fund has added BioGeneration Ventures and the Brabantse Ontwikkelings Maatschappij as shareholders. Dont let your products get skipped. This link will take you to a site maintained by a third party who is solely responsible for its content. 2023 Dr. Krejsa received her doctorate in Toxicology from the University of Washington (2000) and is an Affiliate Professor at U.W. Valuation- $ 1 Billion AstraZeneca Clinical Study Information Center. In 2021, the company was determined as a unicorn. Buyun Chen - Senior Scientist, Clinica.. - Acerta Pharma - ZoomInfo He has extensive experience in clinical operations and clinical development of both small and large-molecule therapies across a range of oncology indications. Acerta Pharma was founded in 2011. Funding Rounds- 4 Mollie began focusing more on financial traffic, SMS, and telephony services in 2007. Buyun Chen has been working as a Senior Scientist, Clinical Pharmacology and Pharmacometrics at Acerta Pharma for 4 years. Dr. Borellini has over 25 years of executive management experience in the pharma/biotechnology industry, especially focused on global oncology drug development, from pre-clinical to on-market stage. By continuing to use this site you are consenting to these choices. About | Kartos Therapeutics Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs). The Netherlands has catapulted itself to the top of the European startup leaderboards, and it is identified as one of the worlds most interconnected economies as well as the fourth-best European country for startup movement, thanks to a holy trinity of a globally competitive talent pool, an abundance of incubator programmes, and a booming tech sector. Flavia holds a PhD in Pharmaceutical Chemistry from the University of Modena (Italy), and completed her post-doctoral training at the NCI. PitchBooks comparison feature gives you a side-by-side look at key metrics for similar companies. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For the last five years (2014 to 2018) Forbes Magazine named Mr. Gordon one of the top 100 venture capitalists in the world when it placed him on the "Forbes Midas List". AstraZeneca completes transaction for majority equity stake investment 121 Oyster Point Blvd Fl 4, South San Francisco, California, 94080, United States. It has yet to officially declare how many people have an account with the company, unlike other European neobanks. Mollies payments solution, which is already used by over 130,000 businesses, provides easy onboarding, clear pricing, no lock-in contracts, leading and local payment options, a wide selection of powerful plugins, local support, and more. The Amsterdam-based cloud communications platform MessageBird has raised a $200 million Series C fundraising round headed by Spark Capital, with the bulk of the funds set aside for a series of acquisitions. In 2016, Mr. Rothbaum also co-founded Kartos Therapeutics following the in-license of an investigational MDM2 inhibitor from Amgen. In Singapore, Hong Kong, Australia, and New Zealand, it even received acquiring licences. When it comes to the number of native unicorns, the Netherlands ranks fourth in Europe. Her previous roles include Senior Director, Pharmacology & Toxicology at Acerta Pharma (2014-2018); Senior Program Scientist, Experimental Medicine at Seattle Genetics (2011-13); Principal Scientist, Mechanistic and Applied Pharmacology at ZymoGenetics (2004-09); and Senior Scientist, BioPrint at Cerep (2001-04). Covey remained in a leadership position, developing effective teams and biomarker strategies for Astrazenecas drug candidates. Mollie raised 25 million euros in a first external investment round in 2019, led by a group of well-known figures from the technology and payments worlds, including Airbnbs chief financial officer Laurence Tosi. Bunq, which began serving the Dutch market, has since expanded throughout Europe, providing mobile banking services in the Netherlands, Belgium, France, Germany, Ireland, Italy, Portugal, and Spain. General McPeak is currently the President of McPeak and Associates, a consulting firm that he founded in 1995. According to recent research by NRC and Dealroom, the Netherlands has twelve unicorns. AstraZeneca completes transaction for majority equity stake investment in Acerta Pharma. Dr. Verstovsek has achieved international acclaim for his leadership in developing landmark MPN therapeutics and have received several awards. Furthermore, Prince Constantijn, the Netherlands startup ambassador, suggested that the Netherlands should develop two more unicorns starting this year. Click cancel to return to AstraZenecas site or continue to proceed. Parque Tecnolgico Zaartu Analyst Briefing Submitters are 7x more likely to receive a qualified connection. Its outstanding university system is a critical contributor to the countrys ability to develop, attract, and retain talent. Since joining Amgen in 2015, Erin has led due diligence processes across several therapeutic areas and technology platforms within Business Development. Bunq is often referred to be a disruptor or challenger bank. Developing novel targeted therapeutics for the treatment of cancer. Elastic was listed on the New York Stock Exchange on October 5, 2018. From 1990 until his retirement from active military service in late 1994, General McPeak was Chief of Staff of the United States Air Force. The Netherlands technology startup ecosystem is prospering, and the country is home to a growing number of unicorns. I have read this warning and will not be using any of the contained product information for clinical purposes. It creates and distributes both software and hardware solutions that allow companies, governments, government agencies, organisations, and individuals to transfer assets securely across the blockchain. It provides the Adyen platform, which combines gateway, risk management, payment processing, acquiring, and settlement to connect merchants to Visa, Mastercard, and other payment methods, along with sales channels like internet, mobile, and point-of-sale. Acerta Pharma - Products, Competitors, Financials, Employees The GitLab software project was the foundation for GitLab Inc. Acerta's lead molecule, acalabrutinib (ACP-196), is a selective and potent inhibitor of BTK. Iain Dukes is currently Chairman of Iovance Biotherapeutics (NASQ:IOVA) and CEO of Theseus Pharmaceuticals and Viriom. As a key Executive Leader he has been directly involved in the processes of growing up Acerta Pharma from 3 employees to 120 employees, increase company valuation from $2 million to $4 billion, acquire 2 compounds from big Pharma, and raise +$500 million in capital from investor Communities. Year Founded: 2012. In 2016, it added business bank accounts. Contact Information Website www.acerta-pharma.com Ownership Status Acquired/Merged Financing Status Formerly VC-backed Tel: +56 (0)2 367 2000 It created its financial system from the bottom up, and with the debut of its app in 2015, it revolutionised banking. In 2012, Mr. Rothbaum co-founded and was the Executive Chairman of Acerta Pharma, a private life sciences company he later sold to AstraZeneca. In this position, he was responsible for the development of the BTK inhibitor program including transitioning the molecule from pre-clinical stage into Phase I and Phase II. GitLab Inc. operates GitLab.com as a freemium service with a subscription option. ACERTA PHARMA BV. Prior to Amgen, Mr. Piacquad was Senior Vice President, Business Development & Licensing at Schering-Plough Corporation. Ahmed Hamdy, MD Medical Allard Kaptein, PhD Discovery Raquel Izumi, PhD Clinical Operations Tjeerd Barf, PhD Chemistry Francisco Salva Finance & Operations Prior to LetsGetChecked, he was the Chief Financial Officer of Blade Therapeutics, Inc., a privately held biotechnology company. The startup wants to challenge the existing quo and build a bank that prioritises its customers, allowing people to live their lives on their terms. PitchBooks non-financial metrics help you gauge a companys traction and growth using web presence and social reach. It includes a blockchain as a service for government integration, a bitcoin payment portfolio, blockchain-based music industry solutions, and a web-based software tool for blockchain application law enforcement. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. It is now developing its business globally, with offices in Spain, Colombia, Mxico, and the Netherlands, as well as plans to open offices in many more countries, giving more people the chance to earn a living doing what they enjoy. Prior to joining Kartos, he was the program lead for rovalpituzumab tesirine at Stemcentrx, prior to its acquisition by AbbVie. Flow Traders has cultivated a strong team-oriented culture, is constantly growing in foreign markets and is always on the lookout for new talent. It paid US$2.5 billion upfront and an additional US$1.5 billion after the medication passed further tests. AstraZeneca buy Acerta faked cancer drug data, company admits Copyright 2023 CB Information Services, Inc. All rights reserved. The 3 most popular patent topics include: Immunology, Clusters of differentiation, Immune system, Monoclonal antibodies, Cancer treatments. Currently, Mr. Rothbaum is a board member and its largest shareholder. Acerta Pharma Company Profile | Management and Employees List - Datanyze Mr. Sandler received his BS in Engineering from Tufts University and his MBA from the University of Michigan. Digital assets PaaS, data analytics, lightning network, property rights registration, voting, and a chain hub are some of its software offerings. Carl received a PhD in Molecular Biology from the Massachusetts Institute of Technology (1993) and a Bachelor of Arts Degree from Harvard College (1987). His role as a Leader in the Clinical Development field is a result of the multiple responsibilities and duties he has undertaken in the Pharmaceutical industry: Andes Biotechnologies Risk management, revenue optimization, customer insights, and more are all included. Acerta Pharma is an AstraZeneca European R&D centre focused on the research and development of new revolutionary medications for the treatment of haematological malignancies. The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution. our sites and services. He is listed as an inventor on many scientific patents and is published in numerous medical journals, including the NEJM, the Lancet and the Journal of Clinical Oncology. Acerta Pharma BV: ClinicalTrials.gov Identifier: NCT02475681 Other Study ID Numbers: ACE-CL-007 : First Posted: June 19, 2015 Key Record Dates: Results First Posted: January 10, 2023: Last Update Posted: March 29, 2023 Last Verified: March 2023 Individual Participant Data (IPD) Sharing Statement: Plan to Share IPD: Claim your profile to get in front of buyers, investors, and analysts. Through private blogs, websites, and other channels, affiliates can market and sell content to earn commissions. Mollie is a payment innovator and one of Europes fastest-growing payment service providers. According to a new analysis from NRC and Dealroom, the Netherlands startup ecosystem is thriving, and the country is home to 12 unicorns. AstraZeneca provides this link as a service to website visitors. In 2012, Mr. Rothbaum co-founded and was the Executive Chairman of Acerta Pharma, a private life sciences company he later sold to AstraZeneca. Acerta's lead molecule, acalabrutinib (ACP-196), is a selective and potent inhibitor of BTK. The Enterprise Europe Network assists Dutch enterprises in growing worldwide, as well as encouraging and promoting new businesses through the Startup Delta programme, which aims to integrate the Dutch startup ecosystem into a single hub. Acalabrutinib is a small-molecule oral drug candidate that covalently binds to BTK. In 2016, Mr. Rothbaum also co-founded Kartos Therapeutics following the in-license of an investigational MDM2 inhibitor from Amgen. Acerta Pharma's headquarters is located at Kloosterstraat 9, Oss. With $2.7B ArQule buyout, Merck is latest pharma to jump into Btk race."), while AZ gained Calquence via its $2.5 billion acquisition of a 55% stake in Acerta Pharma B.V . Dr. Countouriotis is the President and Chief Executive Officer and a member of the Board of Directors of Turning Point Therapeutics. Dr. McGreivy brings clinical, strategic, and operational leadership as well as extensive experience in the successful development of novel cancer therapies to Kartos, having joined from Adicet Bio where he was CMO. GitLab Inc. is an open-source company that makes GitLab, a DevOps tool that integrates the ability to develop, protect, and run software in one application. GitLab Inc. now employs people in 65 countries and territories. In 2018, the company was named to Forbes Top 50 fintech companies list. He joined Merck in August 2013. The British Pusher was bought for 35 million dollars towards the end of 2020 by this unicorn. In Europe, the Americas, and Asia, Flow Traders is a global electronic liquidity provider focusing on exchange-traded products (ETPs). Our Translational Medicine (TM) team are actively implementing MRD endpoints in our clinical trials to understand what treatments can drive to MRD undetectable levels. In February 2016, AstraZeneca acquired a majority share of Acerta Pharma via a USD $4 billion investment and is a committed partner to the development of these innovative drugs. Valuation- $ 1 Billion in Economics from San Diego State College and an M.S. The unicorn is a digital product content distribution platform. Mol founded Zaypay in 2007 to promote micropayments via SMS and 0900 numbers, and to handle these activities. Processes for the preparation of 4-{8-amino-3-[(2s)-1-(but-2-ynoyl)-pyrrolidin-2-yl]imidazo[1,5-a]-pyrazin-1-yl}n-(pyridin-2-yl)-benzamide, To view Acerta Pharmas complete valuation and funding history, request access, Youre viewing 2 of 57 competitors. The core functionality is released under an open-source licence, whereas the additional functionality, like code owners, multiple issue assignees, dependency scanning, and insights, is released under a private licence. IOVANCE logo is a trademark owned, See Our Research Partners & Collaborators. Status: Private. In 2021, Bunq became the first digital bank to offer mortgages. Initially, the company only sold text messages to businesses. Acerta Pharma Company Profile: Acquisition & Investors | PitchBook You have selected a link that will take you to a site maintained by a third party who is solely responsible for its contents. . Dr. Dukes joined the Iovance Board of Directors and was appointed Chairman of the Board in August 2016. As SVP of Client Solutions at Vaniam Group (2016-19), she led medical and scientific teams and consulted with pharmaceutical clients commercializing in hematology. It creates methods using publicly available data and order kinds that are non-controversial, simple, and transparent. Claim your profile to get in front of buyers, investors, and analysts. He was Chairman of the Board of Coast Plating, Inc., a privately held turnkey provider of metal processing and metal finishing services, from January 2009 until the company was acquired by Trive Capital and renamed Valence Surface Technologies. It improves consumer and employee search experiences, keeps mission-critical applications running smoothly, and protects against cyber threats via Enterprise Search, Observability, and Security solutions. Calquence is the brand name for Acalabrutinib, the active ingredient in the drug. Hotmart acquired Teachable, an online course and coaching platform that helps people turn their skills and experience into flourishing companies. From 2000 to 2007, Dr. Dukes was Vice President of Scientific and Technology Licensing at GlaxoSmithKline, and prior to that, from 1990 to 1999, he held various positions at Glaxo Wellcome, including Head of Exploratory Development for Metabolic and Urogenital Diseases and Head of Ion Channel Drug Discovery Group. Fax: +56 (0)2 237 2259, 2023 ANDES | BIOTECHNOLOGIES. The unicorn bought US-based SparkPost on April 28, 2021, extending its communication tool offering to include e-mail. Vice President Europe & Site Head Acerta Oss. From July 2010 to December 2017, General McPeak was Chairman of the American Battlefield Monuments Commission. As a member of the Joint Chiefs of Staff, General McPeak was a military advisor to the Secretary of Defense and the President of the United States. The number of funding transactions and prospects for startups is furthermore increasing, indicating that access to business funding is growing. Application search, site search, enterprise search, logging, infrastructure monitoring, application performance management, security analytics (also used to complement SIEM products), and business analytics are all examples of Elasticsearch use cases. At this point, Mollies plan is not to try to launch in 60 countries all at once, since the product offer is really about a high level of customisation and a considerable amount of local market expertise. The startup believes in helping enterprises, their employees, and their customers get the results that matter at Elastic. AcertaPharma has raised a total of $60M in funding over 1 round. It allows merchants to accept recurring payments and manage subscriptions through its API interface. Acalabrutinib is a highly selective, irreversible, second generation BTK inhibitor, with approximately 1,000 patients treated to date in clinical studies across the entire development programme. By continuing to browse the site, you agree to accept our use of cookies. Acerta Pharma has 8 executives. It oversees the solution for automatic response. For the past four years, Great Place to Work has named it one of the top medium-sized technology startups to work for. Dr. Dukes serves on the Board of Directors of Themis Biosciences, Ikena Oncology, KaNDy Therapeutics (previously as Chairman), NeRRe Therapeutics, ReViral Limited and ENYO Therapeutics. He holds an M.J. and D.Phil. AstraZeneca today announced that it has completed the transaction to acquire a majority equity stake in Acerta Pharma, a privately-owned biopharmaceutical company based in the Netherlands and US. . The investment also establishes in-house expertise for AstraZeneca in blood cancers, through the substantial expertise offered by Acertas approximately 150 employees. Her MS is from the University of Michigan. It provides semiconductors and microelectronics, servers, datacenter building, datacenters in marine containers, and immersion cooling on the hardware side. Swiftype, a developer of search and index software, was bought by Elastic in 2017. eBay, Wikipedia, Yelp, Lyft, and Tinder all employ Elasticsearch technology. For enterprises, it is a payment issuance solution. It was one of the first digital banks in Holland to start lending for retail mortgages. Todd holds a BA in Physiology and Cell Biology from UC Santa Barbara. Veeva ID: Z4-46798Date of next review: August 2024. Several Dutch unicorns are located in Amsterdam, which has a thriving startup culture and a tech industry employing more than 69,000 people. Acerta Pharma B.V. - Company Profiles - BCIQ He was a Fellow at The Rockefeller University from 1993 to 1995. The startup currently has no restrictions on the size of a single file as long as it stays under the 10 GB limit. As a key Executive Leader he has been directly involved in the processes of growing up Acerta Pharma from 3 employees to 120 employees, increase company valuation from $2 million to $4 billion, acquire 2 compounds from big Pharma, and raise +$500 million in capital from investor Communities. It believes there should be no more paperwork, branch visits, or bureaucracy, just the flexibility to focus on what matters most- running your company. our sites and services. It helps companies cut development costs and time to market while increasing developer productivity by reducing cycle time from weeks to minutes. Clients send messages through the website or API, which are then converted to speech. It uses organised deployment pipelines to push the CI-validated code into the application. Bitfurys private blockchain architecture, Exonum, its advanced analytics platform Crystal Blockchain, and its specialised engineering team for the open-source Lightning Network, LightningPeach, deliver software for some of the worlds most cutting-edge applications. Flow Traders promotes a strong team-oriented culture in which employees are recognised for their contributions to the organisation as a whole rather than just in their immediate area of responsibility. BOM and BioGeneration Ventures are the most recent investors. Its goal is to restore faith in the world by inventing at every level of technology hardware, security, and software to restore transparency and trust. He received his doctorate in Cellular and Molecular Biology from West Virginia University, and is a Fellow of the Academy of Toxicological Sciences. Adyen was ranked 10th on the Forbes Cloud 100 list. Hotmart Sparkle, Teachable, and Klickpages are among its brands.
Seminole County Police Calls,
Celebrities In Nashville This Weekend,
Articles P